Home / Mumbai / Mumbai News / Article /
Content posted against Serum Institute of India prima facie defamatory: HC
Updated On: 05 June, 2023 01:26 PM IST | Mumbai | mid-day online correspondent
The SII filed a defamation suit in December 2022 seeking damages to the tune of Rs 100 crore from the two individuals and their organisations for allegedly posting erroneous content against the company and its COVID-19 vaccine Covishield
Listen to this article :
Bombay High Court. File Pic
The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and directed them to delete it, reported news agency PTI.
A single bench of Justice R I Chagla also temporarily restrained them from posting any content against the company.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT